Literature DB >> 22161967

Identification of 83 novel alpha-mannosidosis-associated sequence variants: functional analysis of MAN2B1 missense mutations.

Hilde Monica Frostad Riise Stensland1, Helle Bagterp Klenow, Lam Van Nguyen, Gaute Martin Hansen, Dag Malm, Øivind Nilssen.   

Abstract

The lysosomal storage disorder alpha-mannosidosis is caused by deficiency of the enzyme lysosomal alpha-mannosidase (MAN2B1). In this study, 96 disease-associated sequence variants were identified in 130 unrelated alpha-mannosidosis patients from 30 countries. Eighty-three novel variants were detected, extending the mutation spectrum from 42 to 125. In total, 256 of the 260 mutant alleles (98.5%) were identified. Most of the variants were unique to each family, however, c.2248C>T (p.Arg750Trp) was detected in 50 patients from 16 countries, and accounted for 27.3% of the disease alleles. Haplotype analysis revealed that the c.2248T variant was present on four MAN2B1 haplotype backgrounds, where one major haplotype accounted for 95% of the alleles. The distribution of the c.2248T-associated haplotypes differed remarkably from those of the control populations, suggesting that c.2248C>T has occurred on a few ancestral haplotypes where the major haplotype subsequently has spread by founder effects. The disease-associated missense mutations were introduced into the human MAN2B1 cDNA, expressed in cell culture and assayed for MAN2B1 activity. The majority of the variants were inactive, however, ten showed MAN2B1 activity above background, and more detailed studies are necessary to further evaluate the pathogenicity of these variants.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22161967     DOI: 10.1002/humu.22005

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  The natural course and complications of alpha-mannosidosis--a retrospective and descriptive study.

Authors:  Dag Malm; Hilde Monica Frostad Riise Stensland; Øyvind Edvardsen; Øivind Nilssen
Journal:  J Inherit Metab Dis       Date:  2013-06-06       Impact factor: 4.982

2.  Benefits of clinical criteria and high-throughput sequencing for diagnosing children with syndromic craniosynostosis.

Authors:  Elin Tønne; Bernt Johan Due-Tønnessen; Inger-Lise Mero; Ulrikke Straume Wiig; Mari Ann Kulseth; Magnus Dehli Vigeland; Ying Sheng; Charlotte von der Lippe; Kristian Tveten; Torstein Ragnar Meling; Eirik Helseth; Ketil Riddervold Heimdal
Journal:  Eur J Hum Genet       Date:  2020-12-07       Impact factor: 4.246

3.  Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation.

Authors:  Line Borgwardt; Hilde Monica Frostad Riise Stensland; Klaus Juul Olsen; Flemming Wibrand; Helle Bagterp Klenow; Michael Beck; Yasmina Amraoui; Laila Arash; Jens Fogh; Øivind Nilssen; Christine I Dali; Allan Meldgaard Lund
Journal:  Orphanet J Rare Dis       Date:  2015-06-06       Impact factor: 4.123

4.  Clinical implementation of gene panel testing for lysosomal storage diseases.

Authors:  Alexander Gheldof; Sara Seneca; Katrien Stouffs; Willy Lissens; Anna Jansen; Hilde Laeremans; Patrick Verloo; An-Sofie Schoonjans; Marije Meuwissen; Diana Barca; Geert Martens; Linda De Meirleir
Journal:  Mol Genet Genomic Med       Date:  2018-12-11       Impact factor: 2.183

Review 5.  Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism.

Authors:  Emily Y Tan; Jaap Jan Boelens; Simon A Jones; Robert F Wynn
Journal:  Front Pediatr       Date:  2019-10-25       Impact factor: 3.418

6.  Alpha-Mannosidosis from India due to a Novel Pathogenic Variant in MAN2B1 Gene.

Authors:  Vykuntaraju Kammasandra Gowda; Varunvenkat M Srinivasan; Ashwin V Sardesai; Sanjay K Shivappa
Journal:  J Pediatr Neurosci       Date:  2021-07-12

7.  Natural history of alpha mannosidosis a longitudinal study.

Authors:  Michael Beck; Klaus J Olsen; James E Wraith; Jiri Zeman; Jean-Claude Michalski; Paul Saftig; Jens Fogh; Dag Malm
Journal:  Orphanet J Rare Dis       Date:  2013-06-20       Impact factor: 4.123

8.  Chronic enzyme replacement therapy ameliorates neuropathology in alpha-mannosidosis mice.

Authors:  Markus Damme; Stijn Stroobants; Meike Lüdemann; Michelle Rothaug; Renate Lüllmann-Rauch; Hans Christian Beck; Annika Ericsson; Claes Andersson; Jens Fogh; Rudi D'Hooge; Paul Saftig; Judith Blanz
Journal:  Ann Clin Transl Neurol       Date:  2015-09-19       Impact factor: 4.511

Review 9.  Alpha-Mannosidosis: Therapeutic Strategies.

Authors:  Maria Rachele Ceccarini; Michela Codini; Carmela Conte; Federica Patria; Samuela Cataldi; Matteo Bertelli; Elisabetta Albi; Tommaso Beccari
Journal:  Int J Mol Sci       Date:  2018-05-17       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.